文献速递垂体与肾上腺疾病

原发性醛固酮增多症筛查患者中肾上腺偶发瘤的后续检出率

Incidence of Adrenal Masses Eventually Discovered in Patients Screened for Primary Aldosteronism.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

该回顾性队列研究基于加拿大阿尔伯塔省数据库,纳入2012至2019年接受醛固酮肾素比值(ARR)检测的高血压患者,评估ARR后0至12年内因任何原因行腹部影像学检查时肾上腺肿块的检出率,发现无预先肾上腺影像指征者需筛查14例(11-18)才检出1例肾上腺肿块,提示高疑诊PA时可考虑常规肾上腺影像。

要点

  • ARR筛查后因其他指征行腹部影像者中,肾上腺肿块检出率7.2%(5.6-9.2%)。
  • 无预先肾上腺影像指征者,需筛查14例(11-18)检出1例肾上腺肿块。
  • 高疑诊原发性醛固酮增多症时,可考虑常规肾上腺影像以辅助诊断。

核心结论

  • 在因PA筛查而行ARR检测但无预先或后续定向肾上腺影像的患者中,每14例有1例 later 因其他指征行影像时发现肾上腺肿块。

研究设计与样本

  • 回顾性队列研究,基于加拿大阿尔伯塔省行政与临床影像及生化数据库,纳入2012至2019年高血压且检测ARR的患者。

主要发现

  • 6942例独特高血压患者中,1462例(21%)在ARR后行影像检查,其中912例(62.4%)影像指征与高血压/肾上腺无关,中位时间为ARR后771天(69-1577)。
  • 影像中肾上腺肿块检出率估计为7.2%(5.6-9.2%),中位大小1.4 cm(1.1-2.3),远高于现代未选择成人中肾上腺偶发瘤患病率系列。
  • 无预先肾上腺影像指征者,检出肾上腺肿块需筛查人数为14(11-18)。

临床怎么用

  • 当原发性醛固酮增多症疑诊较高时,可考虑常规肾上腺影像检查,以更新内分泌性高血压的验前概率并指导后续检查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Biochemical screening for endocrine hypertension may be complex; the known presence of an adrenal mass markedly increases the pretest probability for adrenal hypertension and may inform diagnostic efforts. OBJECTIVE: Model the potential incidence of adrenal masses that may be detected by routine adrenal imaging in patients with suspected endocrine hypertension. DESIGN: Retrospective cohort study. SETTING: Provincial administrative and clinical databases for radiology and biochemistry, Alberta, Canada. PARTICIPANTS: Patients with hypertension and any measurement of aldosterone-renin ratio (ARR), 2012 to 2019. MAIN MEASURES: Radiology report of any computed tomography or magnetic resonance imaging abdomen performed for any reason 0 to 12 years following ARR. Patients with any pre-ARR imaging data between 2002 and 2024 were excluded. The presence of adrenal mass, size, and density were recorded and stratified by imaging indication. RESULTS: Of 6942 unique hypertension patients with ARR, 1462 (21%) had imaging done at some point after ARR, 912 (62.4%) for indications unrelated to hypertension/adrenal and at a median 771 days (69-1577) post ARR. The incidence rate estimate was 7.2% (5.6-9.2%) of scans showed adrenal mass, median 1.4 cm (1.1-2.3), a rate well above the modern series of adrenal incidentaloma prevalence in unselected adults. The number needed to screen in this population was 14 (11-18) to detect an adrenal mass without a priori indication for adrenal imaging. CONCLUSION: Among patients screened for PA but without prior or subsequent directed adrenal imaging, 1 in 14 were later found to have an adrenal mass on imaging done for other indications. Given the impact on pretest probability for endocrine hypertension and further investigation steps, routine adrenal imaging might be considered whenever PA suspicion is high.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Kline GA, Low J, Burkart JJ, et al. Incidence of Adrenal Masses Eventually Discovered in Patients Screened for Primary Aldosteronism. J Clin Endocrinol Metab. 2026. PMID: 40581375. doi:10.1210/clinem/dgaf371

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。